December 18 at 11:00AM ET | DTA Q4 Town Hall | Members-Only
Join us for the final DTA Town Hall of 2024. We will discuss the accomplishments and progress made in 2024 and take a look at what’s ahead for 2025.
Contact Stephanie for the members-only registration link.
_______________________________________________________________________________________________________________
January 22-24 | Irvine, CA | DTA Reimbursement Intensive Workshop | Ticketed
This 40 person workshop will provide a comprehensive understanding and strategy framework for the key payor landscapes for digital therapeutics, including government, commercial, employer, and direct-to-consumer models.
You’ll explore the latest trends and challenges in securing reimbursement from Medicare, Medicaid, VA, and commercial payors, and gain insight into the pathways for inpatient, outpatient, and durable medical equipment services.
_______________________________________________________________________________________________________________
January 28 at 1:00PM ET | Mapping the Patient Odyssey for DTx | Free
Digital Therapeutics (DTx) offer innovative solutions to improve patient health, but successful adoption requires a deep understanding of the patient journey. This webinar introduces a Patient Odyssey resource, designed to help DTx companies navigate the complexities of engaging patients at every stage of their healthcare experience.
_______________________________________________________________________________________________________________
February 5 at 2:00PM Singapore / 1:00AM ET | Exploring Regulatory and Reimbursement Pathways for DTx: Asia Pacific | Free
Join us for a webinar series where we delve into the complexities of regulatory and reimbursement pathways for digital therapeutics around the globe. Each session in this series will focus on a specific country or region, providing a comprehensive overview of the landscape for digital therapeutics.
In this session, we will focus on a specific the Asia-Pacific region, providing a comprehensive overview of the regulatory and reimbursement frameworks for digital therapeutics. We will review the frameworks in countries including South Korea, Japan, China, Singapore, and Australia.
_______________________________________________________________________________________________________________